These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 8105231)

  • 1. Inositol 1,4,5-trisphosphate metabolism in red blood cells from individuals susceptible to malignant hyperpyrexia.
    Foster PS; Gesini E; Denborough MA
    Lancet; 1993 Oct; 342(8877):986-7. PubMed ID: 8105231
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP in normal and malignant hyperpyrexia susceptible individuals following exercise.
    Stanec A; Stefano G
    Br J Anaesth; 1984 Nov; 56(11):1243-6. PubMed ID: 6091707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol-1,4,5-trisphosphate and malignant hyperthermia.
    Scholz J; Troll U; Schulte am Esch J; Hartung E; Patten M; Sandig P; Schmitz W
    Lancet; 1991 Jun; 337(8753):1361. PubMed ID: 1674350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia and inositol phosphate metabolism in the heart and skeletal musculature].
    Scholz J; Roewer N; Troll U; Patten M; Schmitz W; Scholz H; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):450-3. PubMed ID: 1786304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise, cyclic AMP and malignant hyperpyrexia susceptibility.
    Campbell IT
    Br J Anaesth; 1985 Aug; 57(8):837-8. PubMed ID: 2990512
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiological role of the serotonin system in malignant hyperthermia.
    Wappler F; Fiege M; Schulte am Esch J
    Br J Anaesth; 2001 Nov; 87(5):794-8. PubMed ID: 11878537
    [No Abstract]   [Full Text] [Related]  

  • 7. Halothane induced disorder of red cell membranes of subjects susceptible to malignant hyperthermia.
    Ohnishi ST; Ohnishi T
    Cell Biochem Funct; 1988 Oct; 6(4):257-61. PubMed ID: 2847881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory mechanisms of calcium signals].
    Iino M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):182-7. PubMed ID: 10879063
    [No Abstract]   [Full Text] [Related]  

  • 9. A laboratory animal model for malignant hyperpyrexia.
    Durbin CG; Rosenberg H
    J Pharmacol Exp Ther; 1979 Jul; 210(1):70-4. PubMed ID: 36478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperpyrexia.
    Denborough MA
    Compr Ther; 1975 Dec; 1(8):51-6. PubMed ID: 770064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid status in malignant hyperpyrexia.
    Lister D
    Br J Anaesth; 1973 Jan; 45(1):115. PubMed ID: 4696420
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function in malignant hyperpyrexia.
    Sullivan JS; Ardlie NG; Denborough MA
    Br J Anaesth; 1982 Aug; 54(8):900-1. PubMed ID: 7104140
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemolysis and hyperkalemia complicate malignant hyperpyrexia during anesthetic death.
    Ward RJ; Eisele JW; Reay DT; Horton WG
    J Forensic Sci; 1986 Apr; 31(2):543-5. PubMed ID: 3711829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test.
    Anetseder M; Hager M; Müller CR; Roewer N
    Lancet; 2002 May; 359(9317):1579-80. PubMed ID: 12047971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
    Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
    Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biochemical abnormality found in muscle from unstressed malignant-hyperpyrexia-susceptible humans.
    Ellis FR; Halsall PJ; Allam P; Hay E
    Biochem Soc Trans; 1984 Jun; 12(3):357-8. PubMed ID: 6734892
    [No Abstract]   [Full Text] [Related]  

  • 18. Propofol in patients susceptible to malignant hyperpyrexia.
    Cartwright DP
    Anaesthesia; 1989 Feb; 44(2):173. PubMed ID: 2784640
    [No Abstract]   [Full Text] [Related]  

  • 19. Inositol 1,4,5-trisphosphate receptor localization in the brain of a weakly electric fish (Apteronotus leptorhynchus) with emphasis on the electrosensory system.
    Berman NJ; Hincke MT; Maler L
    J Comp Neurol; 1995 Oct; 361(3):512-24. PubMed ID: 8550896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.